Article
Preparing for implementation of long-acting injectable cabotegravir for HIV pre-exposure prophylaxis within the Brazilian public health system: The ImPrEP CAB Brasil Study
2023-11-20
Abstract excerpt
<h4>Introduction: </h4> Although long-acting injectable cabotegravir (CAB-LA) PrEP has proven efficacious for HIV prevention in clinical trials, additional research is needed to guide effective implementation in real world settings. <h4>Methods: </h4> ImPrEP CAB-Brasil is an implementation study of same-day delivery of CAB-LA PrEP for young sexual and gender minorities (SGM; aged 18-30 years) in six existing oral...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 65dd69ce-c171-5959-b24e-2a61fc6ea563
- DOI
- 10.21203/rs.3.rs-3607464/v1
